Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations [Phase 4]
A Phase 4 trial evaluating empagliflozin in type 2 diabetes and chronic kidney disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery [Phase 4]
Clinical trial update on the effects of an SGLT2 inhibitor in patients with type 2 diabetes undergoing cardiac surgery (Phase 4).
-
FDA approval · 2021-10-01FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO XR, a fixed-dose combination of linagliptin and metformin hydrochloride, updating…
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for TG103 Injection in overweight/obese subjects with Type 2 Diabetes.
-
FDA approval · 2021-09-30FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for TRULICITY (dulaglutide) submitted by Eli Lilly and Company, updating the label as requested in t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia [Phase 2, Phase 3]
Phase 2/3 trial assessing autologous bone marrow aspirate concentrate for no-option critical limb ischemia completed.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients [Phase 3]
A Phase 3 trial evaluating sitagliptin for COVID-19 in patients with type 2 diabetes (diabetes mellitus) with unclear current status.
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings [Phase 3]
Phase 3 trial update evaluating medical assistant health coaching for type 2 diabetes in diverse primary care settings has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Onduo Virtual Diabetes Clinic Study [NA]
A completed diabetes study for Type 2 diabetes with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) [Phase 2]
Phase 2 pilot study evaluating the safety of oral insulin in patients with nonalcoholic steatohepatitis (NASH) and type 2 diabetes; study co…
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update of insulin degludec injection in subjects with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes [NA]
Completed clinical trial with posted results for a study involving Type 2 Diabetes Mellitus and Obesity under REAL HEALTH-Diabetes: Reach Ah…
-
FDA approval · 2021-09-17FDA Approved: STEGLUJAN — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for STEGLUJAN (ertugliflozin and sitagliptin) from Merck Sharp & Dohme LLC.
-
FDA approval · 2021-09-17FDA Approved: STEGLATRO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for STEGLATRO (ertugliflozin) from Merck Sharp & Dohme LLC, resulting in changes to the product’s la…
-
FDA label_change · 2021-09-17FDA Approved: SEGLUROMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Segluromet (ertugliflozin and metformin HCl) submitted by Merck to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Memory Aid by Intranasal Insulin in Diabetes (MemAID) [Phase 2]
Phase 2 clinical trial update for MemAID investigating intranasal insulin in Type 2 diabetes; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber [NA]
A completed clinical trial investigating a novel approach to assessing metabolic flexibility in Type 2 diabetes within a respiratory chamber…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: A Study of Supaglutide in Chinese Type 2 Diabetes Patients [Phase 2]
Phase 2 trial of Supaglutide in Chinese patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Tolerance & Responsiveness Improvement for Metformin (TRIM) [Phase 4]
Phase 4 clinical trial update on tolerance and responsiveness improvement for metformin in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Canakinumab in Patients With COVID-19 and Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating canakinumab in patients with COVID-19 and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI) [Phase 4]
A Phase 4 clinical trial assessing whether SGLT-2 inhibitors can prevent post-procedural renal and cardiovascular complications after PCI in…
-
FDA approval · 2021-08-31FDA Approved: LINAGLIPTIN — Original Application (Sunshine Lake Pharma Co., Ltd.)
FDA approved the original application for linagliptin by Sunshine Lake Pharma Co., Ltd., delivering a generic version of the DPP-4 inhibitor…
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept. [Phase 4]
A Phase 4 proof-of-concept study evaluating the effectiveness of combining exenatide with dapagliflozin on 24-hour glucose variability measu…
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects [Phase 3]
Phase 3 trial update showing long-term efficacy and safety of HMS5552 added to metformin in type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Long-term Efficacy and Safety of HMS5552 in T2DM Subjects [Phase 3]
Phase 3 trial update reporting long-term efficacy and safety of HMS5552 in adults with Type 2 diabetes mellitus.